Mike Dixon
Breast Cancer Now Edinburgh Research Team
Research in a Nutshell
The Breast Cancer Now Edinburgh Research Team aims to investigate the mechanisms of resistance to endocrine therapy in breast cancer and develop clinically-applicable approaches to identify patients who are at higher risk of disease progression or relapse.
People |
|
| Professor J Michael Dixon OBE |
Professor of Surgery and Consultant Surgeon |
| Andrew Sims | Senior Research Fellow and Group Leader |
| Arran Turnbull | Translational Oncology Group |
| Carlos Martinez-Perez | Postdoctoral Research Associate |
|
Lorna Renshaw |
Consultant Nurse/NHS |
|
Jane Keys |
Breast Care Nurse/NHS |
|
Jeremy Thomas |
Consultant Pathologist/NHS |
| Monica McGill | Research Coordinator |
| Anu Fernando | Research Technician |
Collaborations
- Various (Edinburgh), Professor Robert Clarke (Georgetown, USA), Professor Charles Perou (UNC, USA), Astra Zeneca (USA), Genomic Health (USA), Roche (USA)
Partners and Funders (current)
- Breast Cancer Now
- Breast Cancer Research Trust
- Breast Cancer Institute
- Georgetown University – National Institute of Health (NIH)
- Astra Zeneca
Scientific Themes
Cancer, stratified medicine, breast cancer, treatment response prediction, window studies, genomics, data integration, meta-analysis
Technology Expertise
Clinical, range of lab-based expertise, microarrays, sequencing, transcriptomics, proteomics and metabolomics analysis, biomarker selection, sample classification, machine learning, survival analysis, statistics